Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group

BACKGROUND: Liposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (5-FU/LV) was effective and well-tolerated in patients with metastatic pancreatic adenocarcinoma (mPAC) that progressed on gemcitabine-based therapy in the global NAPOLI-1 trial. Real-world data may further clarify the out...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Changhoon, Im, Hyeon-Su, Kim, Kyu-pyo, Oh, Do-Youn, Lee, Kyung-Hun, Chon, Hong Jae, Kim, Joo Hoon, Kang, Myoungjoo, Kim, Ilhwan, Lee, Guk Jin, Oh, Sung Yong, Choi, Younak, Choi, Hye Jin, Kim, Seung Tae, Park, Joon Oh, Ryoo, Baek-Yeol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710683/
https://www.ncbi.nlm.nih.gov/pubmed/31489036
http://dx.doi.org/10.1177/1758835919871126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710683/
https://www.ncbi.nlm.nih.gov/pubmed/31489036
http://dx.doi.org/10.1177/1758835919871126

Ejemplares similares